Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKKMarkus Borner, Walter Mingrone, Roger von Moos et al.|Annals of Oncology|2008Cited by 129